# The Fontan Dapagliflozin Pilot Study

> **NCT05741658** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Johns Hopkins University** · enrollment: 29 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Dapagliflozin 10mg Tab

## Key facts

- **NCT ID:** NCT05741658
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-11-08
- **Primary completion:** 2026-04
- **Final completion:** 2026-06
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05741658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05741658, "The Fontan Dapagliflozin Pilot Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05741658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*